The Journal of Immunology, Vol 150, Issue 9 3832-3842, Copyright © 1993 by American Association of Immunologists

ARTICLES

Differential activation of antigen-stimulated suicide and cytokine production pathways in CD4+ T cells is regulated by the antigen- presenting cell [published erratum appears in J Immunol 1993 Jun 15;150(12):5732]

R Wang, KM Murphy, DY Loh, C Weaver and JH Russell
Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110.

Stimulation of the TCR of activated, mature T cells by an APC produces a spectrum of functional responses. Most of those responses positively promote immunity and inflammation. However, death of the responding T cell, which would limit subsequent inflammation, can also result from such stimulation. We compare the Ag threshold necessary to promote inflammation through cytokine production with the Ag threshold necessary to limit inflammation through T cell death. These two responses are independently regulated by the APC and this regulation is selective for both different APC products and different T cell subsets. The costimulator B7 selectively decreases the Ag threshold for cytokine production in Th1 cells with no effect on the Ag threshold for Th1 death. B7 has no effect on the Th2 Ag threshold for cytokine production or death. In contrast, IFN-gamma negatively modulates a macrophage product that selectively increases the threshold of Ag necessary to stimulate death in Th2 cells, but has no effect on cytokine production by Th2 cells or cytokine production or death of Th1 cells. This selective regulation of cytokine production and T cell death may play an important role in both shaping the quality of a given immune response and in providing a general mechanism for the regulation of the immune response by limiting inflammation and through peripheral deletion of inappropriate T cell specificities.

This article has been cited by other articles:

				T. C. Tung, K. Oshima, G. Cui, H. Laks, and L. Sen Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H964 - H973. [Abstract] [Full Text] [PDF]

				T. J. D'Orazio, E. Mayhew, and J. Y. Niederkorn Ocular Immune Privilege Promoted by the Presentation of Peptide on Tolerogenic B Cells in the Spleen. II. Evidence for Presentation by Qa-1 J. Immunol., January 1, 2001; 166(1): 26 - 32. [Abstract] [Full Text] [PDF]

				K. E. Phillips, B. Herring, L. A. Wilson, M. S. Rickford, M. Zhang, C. K. Goldman, J. Y. Tso, and T. A. Waldmann IL-2R{{alpha}}-Directed Monoclonal Antibodies Provide Effective Therapy in a Murine Model of Adult T-Cell Leukemia by a Mechanism other than Blockade of IL-2/IL-2R{{alpha}} Interaction Cancer Res., December 1, 2000; 60(24): 6977 - 6984. [Abstract] [Full Text]

				T. Kezuka and J. W. Streilein Analysis of In Vivo Regulatory Properties of T Cells Activated In Vitro by TGF{beta}2-Treated Antigen Presenting Cells Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1410 - 1421. [Abstract] [Full Text]

				A. Ribas, L. H. Butterfield, B. Hu, V. B. Dissette, W. S. Meng, A. Koh, K. J. Andrews, M. Lee, S. N. Amar, J. A. Glaspy, et al. Immune Deviation and Fas-mediated Deletion Limit Antitumor Activity after Multiple Dendritic Cell Vaccinations in Mice Cancer Res., April 1, 2000; 60(8): 2218 - 2224. [Abstract] [Full Text]

				M. Yoshida, M. Takeuchi, and W. Streilein Participation of Pigment Epithelium of Iris and Ciliary Body in Ocular Immune Privilege. 1. Inhibition of T-Cell Activation In Vitro by Direct Cell-to-Cell Contact Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 811 - 821. [Abstract] [Full Text]

				R. Maroto, X. Shen, and R. Konig Requirement for Efficient Interactions Between CD4 and MHC Class II Molecules for Survival of Resting CD4+ T Lymphocytes In Vivo and for Activation-Induced Cell Death J. Immunol., May 15, 1999; 162(10): 5973 - 5980. [Abstract] [Full Text] [PDF]

				M. Takeuchi, P. Alard, and J. W. Streilein TGF-{beta} Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells J. Immunol., February 15, 1998; 160(4): 1589 - 1597. [Abstract] [Full Text] [PDF]

				X. Zhang, T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis J. Exp. Med., May 19, 1997; 185(10): 1837 - 1849. [Abstract] [Full Text] [PDF]

				J. Critchfield, M. Racke, J. Zuniga-Pflucker, B Cannella, C. Raine, J Goverman, and M. Lenardo T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis Science, February 25, 1994; 263(5150): 1139 - 1143. [Abstract] [PDF]